Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Archives of Osteoporosis
Published in: Archives of Osteoporosis 1/2023

01-12-2023 | Osteoporosis | Original Article

Mortality following fragility hip fracture in China: a record linkage study

Authors: Yiwen Hua, Ying Li, Jiachen Zhou, Lijun Fan, Feng Huang, Zhanpo Wu, Hui Xue, Bingquan Yang, Ping Chen, Yunfeng Rui, Yong Tian, Alireza Moayyeri, Cesar Libanati, Wei Du

Published in: Archives of Osteoporosis | Issue 1/2023

Login to get access

Abstract

Summary

Mortality risk declined over time. Patients with fragility hip fracture experienced an approximate ninefold excess mortality, peaking shortly after fracture, in comparison with that of the general population. Continuous efforts in lowering the occurrence of hip fracture have the potential to improve the survival of the elderly population in China.

Purpose

Hip fractures in older adults often lead to an elevated risk of death. However, few studies investigated mortality risk following hip fracture in mainland China. This retrospective cohort study aimed to evaluate the crude mortality and excess mortality after fragility hip fractures in Lishui residents aged 50 years and older.

Methods

Patients having a fragility hip fracture between October 2013 and August 2019 were identified from the Lishui District Inpatient Data Collection and followed up until August 2020. Death information was ascertained from the linked death registry records. We calculated the follow-up mortality rate and corresponding 95% confidence intervals (CIs) as well as the standard mortality ratios (SMRs) in comparison with the mortality rates of Lishui residents.

Results

During the study period, a total of 808 patients (63.4% females) with an average age of 75 years were admitted for fragility hip fractures. The 1st, 2nd, and 3rd year follow-up mortality rates were 16.51, 6.06, and 5.03 per 100 person-year, respectively. The SMRs were 8.46 (6.94, 9.97), 5.74 (4.86, 6.63), and 4.63 (3.98, 5.27) for the 1st, 2nd, and 3rd year following fragility hip fracture.

Conclusion

Although mortality risk declined over time, patients with fragility hip fracture experienced an approximate ninefold excess mortality, peaking shortly after fracture, in comparison with that of the general population. Continuous efforts in lowering the occurrence of hip fracture have the potential to improve the survival of the elderly population in China.
Appendix
Available only for authorised users
Literature
1.
2.
Rupp M, Walter N, Pfeifer C et al (2021) The incidence of fractures among the adult population of Germany–an analysis from 2009 through 2019. Dtsch Arztebl Int 118:665–669PubMedPubMedCentral
3.
Clynes MA, Harvey NC, Curtis EM, Fuggle NR, Dennison EM, Cooper C (2020) The epidemiology of osteoporosis. Br Med Bull 133:105–117PubMed
4.
Johnell O, Kanis JA (2006) An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 17:1726–1733CrossRefPubMed
5.
Tajeu GS, Delzell E, Smith W et al (2014) Death, debility, and destitution following hip fracture. J Gerontol A Biol Sci Med Sci 69:346–353CrossRefPubMed
6.
7.
Wang CB, Lin CF, Liang WM et al (2013) Excess mortality after hip fracture among the elderly in Taiwan: a nationwide population-based cohort study. Bone 56:147–153CrossRefPubMed
8.
Koh GH, Tai BC, Ang LW et al (2013) All-cause and cause-specific mortality after hip fracture among Chinese women and men. Osteoporos Int 24:1981–1989CrossRefPubMed
9.
10.
Zeng Q, Li N, Wang Q et al (2019) The prevalence of osteoporosis in China, a nationwide, multicenter DXA survey. J Bone Miner Res 34:1789–1797CrossRefPubMed
11.
Zhang C, Feng J, Wang S et al (2020) Incidence of and trends in hip fracture among adults in urban China: a nationwide retrospective cohort study. PLoS Med 17:e1003180CrossRefPubMedPubMedCentral
12.
13.
Chen Y, Jiao Z, Chen P, Fan L, Zhou X, Pu Y et al (2021) Short-term effect of fine particulate matter and ozone on non-accidental mortality and respiratory mortality in Lishui district. China BMC Public Health 21:1661CrossRefPubMed
14.
Toson B, Harvey LA, Close JC (2015) The ICD-10 Charlson Comorbidity Index predicted mortality but not resource utilization following hip fracture. J Clin Epidemiol 68:44–51CrossRefPubMed
15.
Rossen LM, Ahmad FB, Anderson RN et al (2021) Disparities in excess mortality associated with COVID-19 - United States, 2020. MMWR Morb Mortal Wkly Rep 70:1114–1119CrossRefPubMedPubMedCentral
16.
Bischoff HA, Stähelin HB, Dick W et al (2003) Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone Miner Res 18:343–351CrossRefPubMed
17.
Kim KM, Choi HS, Choi MJ, Chung HY (2015) Calcium and vitamin D supplementations: 2015 position statement of the Korean Society for Bone and Mineral Research. J Bone Metab 22:143–149CrossRefPubMedPubMedCentral
18.
Lappe J, Cullen D, Haynatzki G, Recker R, Ahlf R, Thompson K (2008) Calcium and vitamin d supplementation decreases incidence of stress fractures in female navy recruits. J Bone Miner Res 23:741–749CrossRefPubMed
19.
Aibar-Almazán A, Voltes-Martínez A, Castellote-Caballero Y, Afanador-Restrepo DF, Carcelén-Fraile MDC, López-Ruiz E (2022) Current status of the diagnosis and management of osteoporosis. Int J Mol Sci 23:9465CrossRefPubMedPubMedCentral
20.
Ip TP, Leung J, Kung AW (2010) Management of osteoporosis in patients hospitalized for hip fractures. Osteoporos Int 21:S605–S614CrossRefPubMed
21.
22.
Chakhtoura M, Dagher H, Sharara S et al (2021) Systematic review of major osteoporotic fracture to hip fracture incidence rate ratios worldwide: implications for Fracture Risk Assessment Tool (FRAX)-derived estimates. J Bone Miner Res 36:1942–1956CrossRefPubMed
23.
Yong EL, Ganesan G, Kramer MS, Howe TS, Koh JSB, Thu WP et al (2020) Risk factors and trends associated with mortality among adults with hip fracture in Singapore. JAMA Netw Open 3:e1919706CrossRefPubMed
24.
Yoo JI, Kim HY, Jang S, Lee YK, Ha YC (2020) Risk factors for subsequent hip fractures and fatality after an initial hip fracture in Korea: using nationwide claims data. Arch Osteoporos 15:165CrossRefPubMed
25.
ESHRE Capri Workshop Group (2016) The influence of social factors on gender health. Hum Reprod 31:1631–1637CrossRef
26.
27.
Mustard CA, Kaufert P, Kozyrskyj A, Mayer T (1998) Sex differences in the use of health care services. N Engl J Med 338:1678–1683CrossRefPubMed
28.
McLaughlin D, Vagenas D, Pachana NA, Begum N, Dobson A (2010) Gender differences in social network size and satisfaction in adults in their 70s. J Health Psychol 15:671–679CrossRefPubMed
29.
30.
School of Public Health of Southeast University, Health Committee in Lishui District, Statistics Bureau in Lishui District et al (2020) Lishui Whitebook. Nanjing, China.
31.
Tosteson AN, Gottlieb DJ, Radley DC et al (2007) Excess mortality following hip fracture: the role of underlying health status. Osteoporos Int 18:1463–1472CrossRefPubMedPubMedCentral
32.
Li S, Sun T, Liu Z (2016) Excess mortality of 1 year in elderly hip fracture patients compared with the general population in Beijing. China Arch Osteoporos 11:35CrossRefPubMed
33.
Tsuboi M, Hasegawa Y, Suzuki S et al (2007) Mortality and mobility after hip fracture in Japan: a ten-year follow-up. J Bone Joint Surg Br 89:461–466CrossRefPubMed
34.
Wakasugi M, Kazama JJ, Wada A, Hamano T, Masakane I, Narita I (2020) Long-term excess mortality after hip fracture in hemodialysis patients: a nationwide cohort study in Japan. J Bone Miner Metab 38:718–729CrossRefPubMed
35.
Hoogendijk EO, Afilalo J, Ensrud KE, Kowal P, Onder G, Fried LP (2019) Frailty: implications for clinical practice and public health. Lancet 394:1365–1375CrossRefPubMed
36.
Wang O, Hu Y, Gong S et al (2015) A survey of outcomes and management of patients post fragility fractures in China. Osteoporos Int 26:2631–2640CrossRefPubMed
37.
Chen M, Du Y, Tang W, Yu W, Li H, Zheng S, Cheng Q (2022) Risk factors of mortality and second fracture after elderly hip fracture surgery in Shanghai, China. J Bone Miner Metab 40:951–959CrossRefPubMed
Metadata
Title
Mortality following fragility hip fracture in China: a record linkage study
Authors
Yiwen Hua
Ying Li
Jiachen Zhou
Lijun Fan
Feng Huang
Zhanpo Wu
Hui Xue
Bingquan Yang
Ping Chen
Yunfeng Rui
Yong Tian
Alireza Moayyeri
Cesar Libanati
Wei Du
Publication date
01-12-2023
Publisher
Springer London
Published in
Archives of Osteoporosis / Issue 1/2023
Print ISSN: 1862-3522
Electronic ISSN: 1862-3514
DOI
https://doi.org/10.1007/s11657-023-01304-z

Other articles of this Issue 1/2023

Archives of Osteoporosis 1/2023 Go to the issue

Review Article

Bracing and taping interventions for individuals with vertebral fragility fractures: a systematic review of randomized controlled trials with GRADE assessment

Original Article

Incidence and geographic characteristics of the population with osteoporotic hip fracture in Egypt— by the Egyptian Academy of Bone Health

Original Article

A Delphi consensus on the management of Spanish patients with osteoporosis at high risk of fracture: OSARIDELPHI study

Original Article

Risk factors for mortality after hip fracture surgery in Japan using the National Database of Health Insurance Claims and Specific Health Checkups of Japan

Original Article

Characterization and effectiveness of a Fracture Liaison Services program in Colombia

Review Article

Global prevalence of osteosarcopenic obesity amongst middle aged and older adults: a systematic review and meta-analysis